0
0

Cosmetic Safety Enhancement Act of 2019

10/28/2022, 1:46 AM

Congressional Summary of HR 5279

Cosmetic Safety Enhancement Act of 2019

This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.

Current Status of Bill HR 5279

Bill HR 5279 is currently in the status of Bill Introduced since December 3, 2019. Bill HR 5279 was introduced during Congress 116 and was introduced to the House on December 3, 2019.  Bill HR 5279's most recent activity was Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . as of March 11, 2020

Bipartisan Support of Bill HR 5279

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 5279

Primary Policy Focus

Health

Potential Impact Areas

- Animal protection and human-animal relationships
- Business records
- Congressional oversight
- Consumer affairs
- Cosmetics and personal care
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Inflation and prices
- Internet and video services
- Internet, web applications, social media
- Licensing and registrations
- Manufacturing
- Performance measurement
- Product safety and quality
- User charges and fees

Alternate Title(s) of Bill HR 5279

Cosmetic Safety Enhancement Act of 2019
To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes.
Cosmetic Safety Enhancement Act of 2019

Comments